Comparing the PSMA expression during PCa progression, Figure 2A shows increasing PSMA expression in lymph node metastases, locally advanced/recurrent tumors and distant metastases compared to primary tumors, and lowest expression in benign prostatic glands (ANOVA p < 0.001, Figure 2A). The gene discussed is FOLH1; the disease is posterior cortical atrophy.